Novonesis Temettü
Temettü kriter kontrolleri 0/6
Novonesis is a dividend paying company with a current yield of 0.93%.
Anahtar bilgiler
0.9%
Temettü verimi
-0.1%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | 0.8% |
| Gelecekteki Temettü Verimi | 1.6% |
| Temettü Büyümesi | 3.3% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | DKK 4.000 |
| Ödeme oranı | 108% |
Son temettü güncellemeleri
Recent updates
These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well
Sep 27
An Intrinsic Calculation For Novozymes A/S (CPH:NZYM B) Suggests It's 22% Undervalued
Sep 05Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively
Jul 09Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?
Jun 24Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)
May 02Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively
Apr 07Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?
Mar 26Is Now The Time To Put Novozymes (CPH:NZYM B) On Your Watchlist?
Mar 12Novozymes' (CPH:NZYM B) Profits Appear To Have Quality Issues
Feb 04Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)
Jan 29Is Novozymes (CPH:NZYM B) Using Too Much Debt?
Dec 23Returns On Capital At Novozymes (CPH:NZYM B) Paint A Concerning Picture
Dec 05A Look At The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)
Oct 14These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well
Sep 13The Returns On Capital At Novozymes (CPH:NZYM B) Don't Inspire Confidence
Aug 29Estimating The Fair Value Of Novozymes A/S (CPH:NZYM B)
Jul 13Here's Why Novozymes (CPH:NZYM B) Can Manage Its Debt Responsibly
Jun 13Here's What's Concerning About Novozymes' (CPH:NZYM B) Returns On Capital
May 29Estimating The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)
Apr 12Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: NSIS B is not paying a notable dividend for the Danish market, therefore no need to check if payments are stable.
Büyüyen Temettü: NSIS B is not paying a notable dividend for the Danish market, therefore no need to check if payments are increasing.
Piyasaya Karşı Temettü Getirisi
| Novonesis Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (NSIS B) | 0.9% |
| Pazarın Alt %25'i (DK) | 1.5% |
| Pazarın En İyi %25'i (DK) | 6.0% |
| Sektör Ortalaması (Chemicals) | 2.7% |
| Analist tahmini (NSIS B) (3 yıla kadar) | 1.6% |
Önemli Temettü: NSIS B's dividend (0.93%) isn’t notable compared to the bottom 25% of dividend payers in the Danish market (1.53%).
Yüksek Temettü: NSIS B's dividend (0.93%) is low compared to the top 25% of dividend payers in the Danish market (5.97%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: NSIS B is not paying a notable dividend for the Danish market.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: NSIS B is not paying a notable dividend for the Danish market.